MRIGlobal receives $54 Million NIH Neurological Disorder and Stroke Contract to Support Drug Develop

Specifications:

Name:

MRIGlobal receives $54 Million NIH Neurological Disorder and Stroke Contract to Support Drug Develop

Location:

Kansas City, Missouri

Company:

MRIGlobal

Estimated Cost:

$54 Million

Source:

mriglobal.org

Introduction:

MRIGlobal has been awarded a $54 million contract, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.

Features:

The contract entails process development and preparation of active pharmaceutical ingredients (API); pre-formulation and formulation studies; analytical method development and validation; stability studies; drug product manufacturing, packaging, labeling; and storage and distribution of the drug products for clinical trials.

Thomas M. Sack, Ph.D., President and Chief Executive Officer of MRIGlobal said "We are honored to support NIH in securing drugs that could literally transform the lives of so many impacted by stroke and a multitude of neurological diseases such as Alzheimer Disease, autism, Parkinson's Disease, epilepsy, muscular dystrophy, multiple sclerosis, and migraines."